Pyrazoles

USRE49517E1 · kind E1 · reissue

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Rudolf Schindler · Dresden, DE
• Hans-Joachim Lankau · Weinböhla, DE
• Norbert Höfgen · Radeberg, DE
• Christian Grunwald · Dresden, DE
• Ute Egerland · Radebeul, DE
• Barbara Langen · Radebeul, DE
• Rita Dost · Dresden, DE
• Thorsten Hage · Dürnhart, DE
• Simon Edward Ward · Peacehaven, GB

Key dates

• Filing date: Dec 17, 2020
• Grant date: May 2, 2023
• Expiry date: Dec 17, 2040

Classification

• Technology area (CPC —): General

Abstract

The invention relates to pyrazole derivatives which are NMDA NR2B receptor inhibitors, useful in treating central nervous system diseases.